Jon Frampton
Publications
- 2020
- Published
Author Correction: High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia (Scientific Reports, (2020), 10, 1, (3505), 10.1038/s41598-020-60480-x)
Pierre Cauchy, Paloma Garcia, Jon Frampton & Giacomo Volpe, 1 Dec 2020, In: Scientific Reports. 10, 1, 13109.Research output: Contribution to journal › Comment/debate › peer-review
- Published
High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia
Paloma Garcia, Jon Frampton, 26 Feb 2020, In: Scientific Reports. 10, 1, 3505.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
Giacomo Volpe, Jon Frampton, Jul 2019, In: Leukemia. 33, p. 1608-1619 12 p.Research output: Contribution to journal › Article › peer-review
- 2018
- Published
Fine-tuning Mybl2 is required for proper mesenchymal-to-epithelial transition during somatic reprogramming
Carl Ward, Giacomo Volpe, Pierre Cauchy, Anetta Ptasinska, Jon Frampton & Paloma Garcia, 7 Aug 2018, In: Cell Reports. 24, 6, p. 1496-1511.e8 24 p.Research output: Contribution to journal › Article › peer-review
- Published
Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation
Jon Frampton, 1 Jun 2018, In: Journal of Immunological Methods. 457, p. 66-72Research output: Contribution to journal › Article › peer-review
- Published
Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research
Sudha Sundar, Jean-Baptiste Cazier & Jon Frampton, 15 Feb 2018, In: The Lancet Oncology. 19, 2, p. e102–e112Research output: Contribution to journal › Article › peer-review
- Published
Origin-specific Adhesive Interactions of Mesenchymal Stem Cells with Platelets Influence their Behaviour After Infusion.
Julie Rayes, Stephen Watson, Philip Newsome, Neena Kalia, Jon Frampton, Helen McGettrick & Gerard Nash, Feb 2018, In: Stem cells (Dayton, Ohio).Research output: Contribution to journal › Article › peer-review
- 2017
- Published
Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature
Giacomo Volpe, David Grainger, Carl Ward, Pierre Cauchy, Daniel Coleman, Peter Cockerill, Paloma Garcia & Jon Frampton, 11 Sep 2017, In: Scientific Reports. 7, 11148.Research output: Contribution to journal › Article › peer-review
- Published
Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
Philip Newsome, Jon Frampton & 4 others, , 17 Mar 2017, In: Journal of Biological Chemistry. 292, 11, p. 4755-4763 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Targeting the transcription factor Myb by small-molecule inhibitors
Jon Frampton, 1 Mar 2017, In: Experimental Hematology. 47, p. 31-35Research output: Contribution to journal › Article › peer-review
- 2016
- E-pub ahead of print
Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3
Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- 2015
- E-pub ahead of print
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
Emilie Dasse, Jon Frampton, 2 Dec 2015, In: Blood.Research output: Contribution to journal › Article › peer-review
- Published
Fibrin activates GPVI in human and mouse platelets
Craig Hughes, Jon Frampton & Steve Watson, 24 Sep 2015, In: Blood. 126, 13, p. 1601-1608 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Regulation of the Flt3 gene in haematopoietic stem and early progenitor cells
Giacomo Volpe, Mary Clarke, Paloma Garcia, Alexandros Vegiopoulos, Walter Del Pozzo, Jon Frampton & Stephanie Dumon, 18 Sep 2015, In: PLoS ONE. 10, 9, e0138257.Research output: Contribution to journal › Article › peer-review
- Published
Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut
Dean Kavanagh, Philip Newsome, Jon Frampton & Neena Kalia, 24 Aug 2015, In: Stem Cells. 33, 9, p. 2785-97 13 p.Research output: Contribution to journal › Article › peer-review
- Published
- Published
Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes
Paloma Garcia, Jon Frampton, Feb 2015, In: Stem Cells. 33, 2, p. 479-490 12 p.Research output: Contribution to journal › Article › peer-review
- Published
The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters
Jon Frampton & 1 others, , Jan 2015, In: Cell Research. 25, 1, p. 80-92 13 p.Research output: Contribution to journal › Article › peer-review
- 2014
- Published
Transcriptional pause release is a rate-limiting step for somatic cell reprogramming
Yuan Li & 12 others, , 6 Nov 2014, In: Cell stem cell. 15, 5, p. 574-88 15 p.Research output: Contribution to journal › Article › peer-review
- Published
RAG1/2 knockout pigs with severe combined immunodeficiency
Jon Frampton, 1 Aug 2014, In: Journal of Immunology. 193, 3, p. 1496-503 8 p.Research output: Contribution to journal › Article › peer-review